In our study, MCP-1 was more highly expressed in patients with mild cases of COVID-19 (Fig. 1a), while IP-10 and IL-8 were upregulated in severe COVID-19 patients, but not in mild ones (Fig. 1b, c). This evidence concerns the gene CCL2 and COVID-19.